Skip to content
Screener

Other geography segments

Americas
$64.31M+16.5%
APAC
$9.06M+30.1%

Similar metrics at other companies

Lumentum Holdings Inc. logo
LITEEMEA — Revenue
$52.6M+24.3%
Varonis Systems logo
VRNSEMEA — Revenue
$36.36M+14.5%
Zoom Video Communications, Inc. logo
ZMEMEA — Revenue
$194.92M+5.2%
Helios Technologies logo
HLIOEMEA — Revenue
$57.8M+31.1%
Harmonic logo
HLITEMEA — Revenue
$10.46M+21.3%
AECOM logo
ACMEMEA — Revenue
$545.8M+2.7%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(in thousands)Three months ended March 31, 2026Three months ended March 31, 2025Six months ended March 31, 2026Six months ended March 31, 2025
Americas$64,307$55,189$122,688$108,899
EMEA37,34730,64275,71258,945
APAC9,0616,96216,01313,662
Total$110,715$92,793$214,413$181,506

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's EMEA — revenue?
Twist Bioscience Corporation (TWST) reported EMEA — revenue of $37.35M in Q1 2026.
How has Twist Bioscience Corporation's EMEA — revenue changed year-over-year?
Twist Bioscience Corporation's EMEA — revenue increased by 21.9% year-over-year, from $30.64M to $37.35M.
What is the long-term trend for Twist Bioscience Corporation's EMEA — revenue?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's EMEA — revenue has grown at a 29.5% compound annual growth rate (CAGR), from $44.12M to $124.24M.
What does EMEA — revenue mean?
This metric represents the total net sales generated from customers located within the Europe, Middle East, and Africa (EMEA) geographic region. It reflects the company's market penetration and adoption rate of its synthetic DNA products and services within these specific international markets. Tracking this revenue stream provides insight into the company's global expansion strategy and the relative demand for its semiconductor-based DNA synthesis platform outside of its primary domestic market.

Ask your AI about Twist Bioscience Corporation's emea — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude